NNVC — NanoViricides, Share News
0.000.00%
Last trade - 00:00AMEX HALT ADDITIONAL INFORMATION LAST 4.200000
AMEX RESUMED NANOVIRICIDES
AMEX HALT ADDITIONAL INFORMATION LAST 3.880000
Brief: Nanoviricides Enteres Into Open End Mortgage Note In Favor Of Anil Diwan, Co's Founder, Chairman And President To Loan Co Up To $2 Mln
Brief: Nanoviricides Files For Offering 2.5 Mln Shares Of Co's Common Stock
Brief: Nanoviricides Inc Files For Non Timely 10-Q
Brief: NanoViricides Announces One-For-Twenty Reverse Stock Split
Brief: Nanoviricides Says First Drug Candidate Is On Track For Human Clinical Trials
Brief: Nanoviricides Inc Says Mark Day Appointed As New Member Of Board
Brief: NanoViricides Has Received Favorable FDA Comments On Its Pre-IND Application For The Lead Drug Candidate
Brief: Nanoviricides Says Progressing Toward Clinical Trials for Herpecide Drug Candidate
Brief: NanoViricides Has Requested A Pre-IND Meeting With The US FDA
U.S. STOCKS ON THE MOVE-Barnes & Noble Education, Psychemedics, U.S. homebuilders, Big U.S. banks, Revlon
U.S. STOCKS ON THE MOVE-Big U.S. banks, Barnes & Noble Education, Hertz, Kohl's, Target
U.S. STOCKS ON THE MOVE-Kohl's, Target, Hertz, Atlas Financial, Gaia
NanoViricides surges after update on skin drug
Brief: NanoViricides Reports Excellent Safety Profile Of Its First Drug Candidate In Dermal Treatment Study
Brief: Nanoviricides Announces $2.5 Mln Financing In A Registered Direct Offering
NanoViricides: Jumps on license for shingles virus drug